Antabuse, a drug commonly prescribed to treat alcohol use disorder, may help to restore eyesight in people with genetic retinitis pigmentosa and other disorders associated with retinal degeneration.
Gene therapy that targets retinal ganglion cells with light-sensitive cone opsins helps restore vision in mice. Researchers report a potential human treatment could be available within three years.
Retinal implants may improve image sharpness for those who have lost their vision due to retinitis pigmentosa, a new study reports.
A British woman is able to read the time clearly for the first time in years after receiving a new bionic eye implant.
Researchers have developed a new type of nanowire material that may improve both retinal and brain implants.